Last Price$4.3(4.0%)
Market Cap$211.4B
44.8%
Industry median - 65.7%
5Y Historical average - (274.9%)
(405.8%)
Industry median - (855.0%)
5Y Historical average - (1,053.7%)
(270.5%)
Industry median - (726.1%)
5Y Historical average - (13.5%)
68.6%
Industry median - 83.4%
5Y Historical average - 38.6%
SLN Profitability Rating
SLN Profitability rating
6.3
SLN Profitability rating performance
SLN Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with SLN Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$211.4B | 6.3 | 44.8% | (359.0%) | (354.1%) | (362.3%) | (270.5%) | 68.6% | |
$402.0B | 8.3 | 84.7% | 44.3% | 51.2% | 34.8% | 24.1% | 69.4% | |
$125.5B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$74.0B | 8.1 | 86.7% | 28.3% | 33.1% | 31.1% | 25.3% | 81.5% | |
$38.1B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$31.3B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$27.1B | 6.7 | 84.3% | (30.8%) | (12.2%) | (15.4%) | 32.4% | (312.1%) | |
$14.8B | 7.0 | 92.3% | 1.5% | 6.2% | 0.8% | 5.5% | 721.1% | |
$14.6B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$14.0B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$1,846.9M | 5.8 | 83.1% | (26.3%) | (22.0%) | (25.9%) | (30.4%) | 117.3% |
FAQ
What is the Silence Therapeutics plc (SLN) gross profit margin?
The Silence Therapeutics plc (SLN) gross profit margin is 44.8%, compared to the industry median of 65.7% and the 5-year historical average of (274.9%).
What is the Silence Therapeutics plc (SLN) operating income margin?
The Silence Therapeutics plc (SLN) operating income margin is (405.8%), compared to the industry median of (855.0%)) and the 5-year historical average of (1,053.7%).
What is the Silence Therapeutics plc (SLN) Free Cash Flow (FCF) margin?
The Silence Therapeutics plc (SLN) Free Cash Flow margin is (270.5%), compared to the industry median of (726.1%) and the 5-year historical average of (13.5%).
What is the Silence Therapeutics plc (SLN) earnings quality?
The Silence Therapeutics plc (SLN) earnings quality is 68.6%, compared to the industry median of 83.4% and the 5-year historical average of 38.6%.